BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38401687)

  • 1. ICBP90, an epigenetic regulator, induces DKK3 promoter methylation, promotes glioma progression, and reduces sensitivity to cis-platinum.
    Cao Q; Wang X; Liu J; Dong Y; Wu X; Mi Y; Liu K; Zhang M; Shi Y; Fan R
    Exp Cell Res; 2024 Mar; 436(2):113976. PubMed ID: 38401687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells.
    Xiang T; Li L; Yin X; Zhong L; Peng W; Qiu Z; Ren G; Tao Q
    J Cell Mol Med; 2013 Oct; 17(10):1236-46. PubMed ID: 23890219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3.
    Shailesh H; Siveen KS; Sif S
    J Cell Mol Med; 2021 Feb; 25(3):1583-1600. PubMed ID: 33462997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DKK3 blocked translocation of β-catenin/EMT induced by hypoxia and improved gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell.
    Guo Q; Qin W
    J Cell Mol Med; 2015 Dec; 19(12):2832-41. PubMed ID: 26395974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYCN is a novel oncogenic target in adult B-ALL that activates the Wnt/β-catenin pathway by suppressing DKK3.
    Kong D; Zhao L; Sun L; Fan S; Li H; Zhao Y; Guo Z; Lin L; Cui L; Wang K; Chen W; Zhang Y; Zhou J; Li Y
    J Cell Mol Med; 2018 Jul; 22(7):3627-3637. PubMed ID: 29673070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV Core protein represses DKK3 expression via epigenetic silencing and activates the Wnt/β-catenin signaling pathway during the progression of HCC.
    Wang X; Zhou Y; Wang C; Zhao Y; Cheng Y; Yu S; Li X; Zhang W; Zhang Y; Quan H
    Clin Transl Oncol; 2022 Oct; 24(10):1998-2009. PubMed ID: 35768685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro.
    Gu YM; Ma YH; Zhao WG; Chen J
    World J Gastroenterol; 2011 Sep; 17(33):3810-7. PubMed ID: 21987623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p/DKK3 axis to inactivate β-catenin nuclear translocation and LEF1 translation.
    Hu S; Chang J; Ruan H; Zhi W; Wang X; Zhao F; Ma X; Sun X; Liang Q; Xu H; Wang Y; Yang Y
    Int J Biol Sci; 2021; 17(10):2504-2522. PubMed ID: 34326690
    [No Abstract]   [Full Text] [Related]  

  • 9. KDM1A drives hepatoblastoma progression by activating the Wnt/β-catenin pathway through inhibition of DKK3 transcription.
    Ji C; Chen L; Yuan M; Xie W; Sheng X; Yin Q
    Tissue Cell; 2023 Apr; 81():101989. PubMed ID: 36642006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pax6 regulates the expression of Dkk3 in murine and human cell lines, and altered responses to Wnt signaling are shown in FlpIn-3T3 cells stably expressing either the Pax6 or the Pax6(5a) isoform.
    Forsdahl S; Kiselev Y; Hogseth R; Mjelle JE; Mikkola I
    PLoS One; 2014; 9(7):e102559. PubMed ID: 25029272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer.
    Yue W; Sun Q; Dacic S; Landreneau RJ; Siegfried JM; Yu J; Zhang L
    Carcinogenesis; 2008 Jan; 29(1):84-92. PubMed ID: 18048388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis.
    Cheng JY; Brown TC; Murtha TD; Stenman A; Juhlin CC; Larsson C; Healy JM; Prasad ML; Knoefel WT; Krieg A; Scholl UI; Korah R; Carling T
    BMC Cancer; 2017 Mar; 17(1):164. PubMed ID: 28249601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DKK3 promotes renal fibrosis by increasing MFF-mediated mitochondrial dysfunction in Wnt/β-catenin pathway-dependent manner.
    Song J; Chen Y; Chen Y; Qiu M; Xiang W; Ke B; Fang X
    Ren Fail; 2024 Dec; 46(1):2343817. PubMed ID: 38682264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.
    Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Terada K; Itadani M; Okada N; Hassan NMM; Nagatsuka H; Ikeda T; Nohno T; Fujita S
    Oncol Res; 2018 Jan; 26(1):45-58. PubMed ID: 28470144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
    Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Fujita S
    Int J Oncol; 2019 Mar; 54(3):1021-1032. PubMed ID: 30569110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated MicroRNA-25 Mediates the Migration of Melanoma Cells by Targeting DKK3 through the WNT/β-Catenin Pathway.
    Huo J; Zhang Y; Li R; Wang Y; Wu J; Zhang D
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation of DKK3 modulates docetaxel chemoresistance in human nonsmall cell lung cancer cell.
    Tao L; Huang G; Chen Y; Chen L
    Cancer Biother Radiopharm; 2015 Mar; 30(2):100-6. PubMed ID: 25760729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway.
    Li Q; Shen K; Zhao Y; Ma C; Liu J; Ma J
    J Transl Med; 2013 Dec; 11():302. PubMed ID: 24325785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dickkopf-3 (Dkk3) induces apoptosis in cisplatin-resistant lung adenocarcinoma cells via the Wnt/β-catenin pathway.
    Wang Z; Ma LJ; Kang Y; Li X; Zhang XJ
    Oncol Rep; 2015 Mar; 33(3):1097-106. PubMed ID: 25573172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High DKK3 expression related to immunosuppression was associated with poor prognosis in glioblastoma: machine learning approach.
    Han MH; Min KW; Noh YK; Kim JM; Cheong JH; Ryu JI; Won YD; Koh SH; Myung JK; Park JY; Kwon MJ
    Cancer Immunol Immunother; 2022 Dec; 71(12):3013-3027. PubMed ID: 35599254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.